Thursday, July 16, 2026

Visa of Chinese scientist who edited babies’ genes revoked

Despite criticism from many international health experts, Mr Jiankui maintained that his scientific research and experiments were to help the poor.

• February 23, 2023
He Jiankui
He Jiankui [Photo Credit; MIT Technology Review]

Hong Kong has revoked the visa of He Jiankui, a controversial Chinese scientist who edited the gene of babies.

The Chinese scientist’s visa was revoked for giving false information, the Hong Kong authorities said on Tuesday.

Immigration officials in Hong Kong believed that Mr Jiankui, who sparked international controversy and ethical debate in 2018 after creating the world’s first “gene-edited” babies resistant to HIV, had lied on the application form for a talent scheme.

Nearly five years ago, at an international conference in Hong Kong, Mr Jiankui announced that he had achieved a scientific breakthrough by modifying two embryos before they were placed in their mother’s womb, using a technology known as CRISPR-Cas9.

Hong Kong revoked Jiankui’s work visa and launched an investigation after the public condemned the government in the wake of the news that the convicted scientist was granted one, despite having a criminal record in China for medical malpractice.

“After reviewing the application, the Immigration Department suspected the visa/entry permit was obtained by false representation, and the Director of Immigration had declared the visa/entry permits invalid in accordance with the law, and would conduct a criminal investigation to follow up,” said the Hong Kong government.

In December 2019, a court in Shenzhen, China, sentenced Mr Jiankui to three years’ imprisonment and a fine of £360,320 for breaking China’s regulations by carrying out scientific research and practising medicine without a licence after it was suspended a year earlier.

Despite criticism from many international health experts, Mr Jiankui maintained that his scientific research and experiments were to help the poor.

He opened a laboratory in Beijing solely for developing affordable drugs for rare genetic diseases.

We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.

More from Peoples Gazette

farmers

Agriculture

FG tasks ECOWAS on leveraging financing strategies for agroecology

The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Katsina State

Politics

Katsina youths pledge to deliver over 2 million votes to Atiku

“Katsina State is Atiku’s political base because it is his second home.”

Kogi and Nasarawa states.

States

Stakeholders link illegal mining to security challenges in Kogi, Nasarawa

Mr Oyiguh said, “The health and well-being of residents should take precedence over the economic interests of government or private operators.”

Ex-FUOYE VC Abayomi Adesina

NationWide

Senate confirms ex-FUOYE VC, Fasina, as non-career ambassador

Mr Oshiomhole (APC-Edo North) opposed the former vice-chancellor’s immediate confirmation, citing sexual allegations against him.

illegal migrants

Lagos

Troops raid Lagos building, nab 24 illegal migrants

Mr Yahaya stated that during the operation, 24 foreign nationals comprising 15 males and nine females were apprehended.

Africa

Orange-lipped new monkey ‘Likweli’ species found in DR Congo forest

This is the fifth African monkey species to be discovered over the past seven decades.

Heading 1

20,000 pigs killed in Canada wildland fires

The fire incident at the farm occurred as 200 separate wildfires were burning across different parts of Ontario, prompting evacuation of residents.